Long-term follow-up of height and weight after propranolol treatment for infantile hemangiomas

Jianning Sun, Ruixue Zhao, Ran Huo, Jianhai Bi, Zhiyu Li, Xueqing Li · 2026

Read Long-term follow-up of height and weight after propranolol treatment for infantile hemangiomas by Jianning Sun, Ruixue Zhao, Ran Huo, Jianhai Bi, Zhiyu Li, Xueqing Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13272515.txt.

Description

Jianning Sun and co-authors follow the growth of children treated for a birthmark-like tumor, in a letter published in 2026. The tumors, infantile hemangiomas, are usually treated with oral propranolol, a heart drug that shrinks them. The drug is broadly safe, but reports of side effects exist. Their earlier study of 439 infants found growth normal at age two.

This letter extends the check to five to seven years after treatment. Children who had long steroid treatment were set aside, and dosing records were kept from the first trial, which ran from 2016 to 2018. Heights and weights were compared with national growth standards for Chinese children. Long follow-up of this kind matters to parents, since treatment starts in the first months of life. The letter reports the cohort's later growth against those benchmarks.

Catalog record

CREATORJianning Sun, Ruixue Zhao, Ran Huo, Jianhai Bi, Zhiyu Li, Xueqing Li
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE7 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13272515

Browse the full library · About the Tower of Babel